The role of CEBPα mutations in the progression of myeloid leukemias.

被引:0
|
作者
Shih, LY
Huang, CF
Liang, DC
Lin, TL
Wu, JH
Wang, PN
Dunn, P
Kuo, MC
Tang, CC
机构
[1] Chang Gung Mem Hosp, Div Hematol Oncol, Taipei, Taiwan
[2] Chang Gung Univ, Sch Med, Taipei, Taiwan
[3] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3004
引用
收藏
页码:821A / 821A
页数:1
相关论文
共 50 条
  • [31] The proto-oncogene myb augments transcription of the neuropeptide neuromedin U in human myeloid leukemias.
    Shetzline, Susan E.
    Conlon, Joseph
    Swider, Cezary
    Thalheim, Lindsay
    Gewirtz, Alan M.
    BLOOD, 2006, 108 (11) : 638A - 638A
  • [32] New recurrent mutations in atypical chronic myeloid leukemias
    Chauveau, Aurelie
    HEMATOLOGIE, 2015, 21 (01): : 7 - 8
  • [33] Markers of autoimmune processes in acute leukemias.
    Kryukova, MG
    Kozlov, SA
    Cherepanova, VV
    Kulikova, MM
    Zinovyev, YV
    Ryabov, NV
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1998, 43 (04): : 18 - 19
  • [34] Consensus versus disensus in leukemias. Reply
    Rivera-Luna, R
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1998, 50 (01): : 90 - 90
  • [35] Molecular characterization of distinct hot spot regions on chromosome 7q in myeloid leukemias.
    Dohner, Konstanze
    Habdank, Marianne
    Rucker, Frank G.
    Miller, Simone
    Frohling, Stefan
    Scherer, Stephen W.
    Bullinger, Lars
    Dohner, Hartmut
    BLOOD, 2006, 108 (11) : 665A - 666A
  • [36] Role of autophagy in the progression and suppression of leukemias
    Ekiz, Huseyin Atakan
    Can, Geylani
    Baran, Yusuf
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 81 (03) : 275 - 285
  • [37] Role of co-stimulatory factors for the biology and treatment outcome of acute leukemias.
    Tomaszewska-Toporska, B
    Urbaniak-Kujda, D
    Wolowiec, D
    Jazwiec, B
    Kapelko-Slowik, K
    Medras, E
    Frydecka, I
    Kuliczkowski, K
    BLOOD, 2003, 102 (11) : 229B - 230B
  • [38] Different expression patterns of Meis 1 and Meis 2 in core binding factor acute myeloid leukemias.
    Nomdedeu, JF
    Lasa, A
    Colomer, D
    Fernández, C
    Granada, I
    Carnicer, MJ
    Llorente, A
    Domingo, A
    Acebedo, G
    Tormo, J
    Sierra, J
    BLOOD, 2002, 100 (11) : 202B - 202B
  • [39] Amplification of chromosome 11q23 involving the MLL gene is recurrently observed in myeloid leukemias.
    Michaux, L
    Dierlamm, J
    Stul, M
    Wlodarska, I
    Herens, C
    Beverloo, B
    Duhem, C
    Lecomte, M
    Verhoef, G
    Verellen-Dumoulin, C
    Hagemeijer, A
    BLOOD, 1998, 92 (10) : 78A - 78A
  • [40] Mechanisms of altered myelopoiesis by the oncogene FUS(TLS)ERG of the t(16;21) acute myeloid leukemias.
    Uttam, A
    Auer, H
    Perrotti, D
    BLOOD, 2003, 102 (11) : 581A - 581A